A detailed history of Sanibel Captiva Trust Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Sanibel Captiva Trust Company, Inc. holds 147,708 shares of ABT stock, worth $17.4 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
147,708
Previous 146,086 1.11%
Holding current value
$17.4 Million
Previous $15.2 Billion 10.94%
% of portfolio
0.54%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$100.07 - $118.13 $162,313 - $191,606
1,622 Added 1.11%
147,708 $16.8 Billion
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $199,042 - $222,181
-1,976 Reduced 1.33%
146,086 $15.2 Billion
Q1 2024

May 21, 2024

SELL
$109.52 - $120.96 $464,255 - $512,749
-4,239 Reduced 2.78%
148,062 $16.8 Billion
Q4 2023

Feb 16, 2024

BUY
$90.19 - $110.4 $13.7 Million - $16.8 Million
152,301 New
152,301 $16.8 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sanibel Captiva Trust Company, Inc. Portfolio

Follow Sanibel Captiva Trust Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanibel Captiva Trust Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sanibel Captiva Trust Company, Inc. with notifications on news.